Trxade Group, Inc. Withdraws Its Previously Filed FDA Emergency Use Authorization for Rapid COVID-19 Testing Kit in Response To FDA Guidance
May 07, 2020 17:33 ET
|
Trxade Group, Inc.
TAMPA, FL, May 07, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, announced today that its wholly-owned subsidiary,...
TRxADE Group Reports First Quarter 2020 Financial Results
May 04, 2020 08:00 ET
|
Trxade Group, Inc.
Q1 2020 Revenues Increase 46% to $2.2 Million; Drives Net Income Increase of 44% to $0.2 Million TAMPA, FL, May 04, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc., (NASDAQ: MEDS) (“Trxade” or the...
TRxADE GROUP, INC. Sets Date for 2020 Annual Meeting of Stockholders
April 02, 2020 16:15 ET
|
Trxade Group, Inc.
TAMPA, FL, April 02, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc., (Nasdaq: MEDS)(“Trxade Group” or the “Company”), an integrated telehealth, drug procurement, delivery and healthcare platform that...
Trxade Group, Inc. Files FDA Emergency Use Authorization for Rapid COVID-19 Testing Kit
April 01, 2020 08:05 ET
|
Trxade Group, Inc.
TAMPA, FL, April 01, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (NASDAQ: MEDS) an integrated drug procurement, delivery and healthcare platform, announces its wholly-owned subsidiary, Integra...
TRxADE GROUP, INC. REPORTS 2019 RESULTS
March 30, 2020 08:05 ET
|
Trxade Group, Inc.
Delivered 2019 annual revenues of $7.43 Million (94.1% increase)Total Adjusted EBITDA of $852,647 (249% increase)Launched next generation of Telehealth Platform ( www.Bonumhealth.com ) Launched Drug...
TRxADE GROUP, INC. Announces Exercise of Overallotment Option by Underwriters
February 24, 2020 08:00 ET
|
Trxade Group, Inc.
TAMPA, FL, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc., (Nasdaq: MEDS)(“Trxade Group” or the “Company”), an integrated drug procurement, delivery and healthcare platform that enables price...
TRxADE GROUP, INC. Announces Closing of Firm Commitment Common Stock Offering
February 18, 2020 15:50 ET
|
Trxade Group, Inc.
TAMPA, FL, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc., (Nasdaq: MEDS)(“Trxade Group” or the “Company”), an integrated drug procurement, delivery and healthcare platform that enables price...
TRxADE GROUP, INC. Announces Uplisting to Nasdaq Capital Market, Pricing of $5.2 Million Firm Commitment Public Offering of Common Stock and Effectiveness of Reverse Stock Split
February 13, 2020 09:10 ET
|
Trxade Group, Inc.
Ticker Symbol Change to “MEDS” TAMPA, FL, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc., (Nasdaq: MEDS) (OTCQB: TRXD) (“Trxade Group” or the “Company”), an integrated drug procurement,...
Trxade Group, Inc’s wholly-owned Bonum Health Subsidiary Teams Up with Benzer Pharmacy
November 21, 2019 09:00 ET
|
Trxade Group, Inc.
Plans to launch “Bonum Health Hubs” in Benzer Pharmacies TAMPA, FL, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (OTCQB: TRXD) (“Trxade” or the “Company”), an integrated pharma supply...
Bonum Health Introduces Next Generation Healthcare Resource
November 14, 2019 09:00 ET
|
Trxade Group, Inc.
Coming Soon to a Pharmacy Near You: Introducing the Bonum Health Hub TAMPA, FL, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Bonum Health, subsidiary to Trxade Group, Inc. (OTCQB: TRXD) (“Trxade” or the...